White blood cells, smoking and exercise training
Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. 2007. Systemic Effects of Smoking. CcChest 11, 1557-1566.
Atlanta GA. 2000. Tobacco control: country profiles. American Cancer Society. 38-44.
Walters MJ, Paul-Clark MJ, McMaster SK. 2005. Cigarette smoke activates human monocytes by an oxidant-AP-1 signaling pathway: implications for steroid resistance. Molecular Pharmacology 68, 1343–1353.
Barbieri SS, Weksler BB. 2007. Tobacco smoke cooperates with interleukin-1ß to alter ß -catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo. Federation of American Societies for Experimental Biology 21, 1831–1843.
Weijenberg MP, Feskens EJ,Kromhout D.1996. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arteriosclerosis, Thrombosis, and Vascular Biology 16, 499–503.
DeFronzo RA, Ferrannini E. 1991. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14, 173–194.
Naoya W, Mitsuo F, Ataru T, Takahide O, Yoshio N, Fusanori N, Sae A. 2011. Smoking, white blood cell counts, and TNF system activity in Japanese male subjects with normal glucose tolerance. Tobacco Induced Diseases 9(12), 2-6.
Nakanishi N, Yoshida H, Matsuo Y, Suzuki K, Tatara K. 2002. White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men. Diabetologia 45, 42–48.
McCarty MF. 1999. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. Medical Hypotheses 52, 465–477.
Noriyuki N, Kenji S, Kozo T. 2003. Association between lifestyle and white blood cell count: a study of Japanese male office workers. Occupational Medicine 53(2), 135-137.
Merghani TH, Saeed A, Alawad A. 2012. Changes in plasma IL4, TNFá and CRP in response to regular passive smoking at home among healthy school children in Khartoum, Sudan. African Health Sciences 12(1), 41-47.
Watanabe N, Fukushima M, Taniguchi A, Okumura T, Nomura Y, Nishimura F, Aoyama S. 2011. Smoking, white blood cell counts, and TNF system activity in Japanese male subjects with normal glucose tolerance. Tobacco Induced Diseases 9(1), 12.
Wasserman LR. 1973. Cigarette smoking and secondary polycythemia. Journal of the American Medical Association 224, 1654-1657.
Kapoor D, Jones TH. 2005. Smoking and hormones in health and endocrine disorders. European Journal of Endocrinology 152(4), 491-499.
Gidding SS, Xie X, Liu K, Manolio T, Flack J, Perkins L, Gardin J. 1992. Smoking has race/gender specific effects on resting cardiac function: the CARDIA study. Circulation 82, 877.
Berton G, Cordiano R, Palmieri R, Pianca S, Pagliara V, Palatini P. 2003.C-reactive protein in acute myocardial infarction: association with heart failure. American Heart Journal 145, 1094-1101.
Willems JM, Trompet S, Blauw GJ, Westendorp RG, Craen AJ. 2010. White Blood Cell Count and C – reactive protein are independent predictors of mortality in the oldest old. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 65, 764-768.
John DMB, Phil D. 2004. CRP and other circulatory markers of inflammation in prediction of coronary heart disease. New England Journal of Medicine 350, 1387-1451.
Schwartz J, Weiss ST. 1994. Cigarette smoking and peripheral blood leucocyte differentials. Annals of Epidemiology 4, 236-242.